Delix Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Delix Therapeutics is a Cambridge, Massachusetts-based biotechnology company focusing on non-hallucinogenic versions of psychedelic compounds that support neural plasticity and offer a safer therapeutic profile. The company uses a discovery platform to identify these candidates and is advancing them through preclinical and clinical development, aiming for FDA-approved medicines that patients could use outside a clinical setting. Its work centers on addressing psychiatric and neurological conditions by promoting neural plasticity through novel therapeutics.

Delix is a smaller biotechnology firm based in Cambridge, Massachusetts. A notable recent development is that in 2026 Dr. Aaron Koenig left his role as Chief Medical Officer.

Sign up for free to view info

Company overview Employee directory